A rapid release tablet involves as an active ingredient tolfenamic acid or {HEAD ~ its pharmaceutically acceptable salts} having {TAIL ~ a mean particle size} of <10 μm, alginic acid or its pharmaceutically acceptable salts in an amount of 1.5 6.0% by weight, and a superdisintegrant in an amount of at least 6% by weight 
having
A rapid release tablet involves as an active ingredient tolfenamic acid or { HEAD ~ its pharmaceutically acceptable salts } having { TAIL ~ a mean particle size } of < 10 μm , alginic acid or its pharmaceutically acceptable salts in an amount of 1.5 6.0 % by weight , and a superdisintegrant in an amount of at least 6 % by weight
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH